💥DPA-CKD Trial results announced
⚡️Dapagliflozin lowered the risk of kidney failure and lowered mortality in both diabetic & non-diabetic patients
⚡️No episodes of hypoglycemia in non-diabetic patients
#ESCCongress #DAPACKD
Here is the full presentation (in short clips)
***DAPA-CKD
DAPA-CKD Trial - Baseline Characteristics
👉🏽 academic.oup.com/ndt/advance-ar…
@NDTsocial
Great summary of the DAPA-CKD Trial by @hswapnil 👇🏽
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.